Comparison of the Effect of Vessel Size Imaging and Cerebral Blood Volume Derived from Perfusion MR Imaging on Glioma Grading

References

1. 1.↵
   2. Caulo M,
   3. Panara V,
   4. Tortora D, et al

   . Data-driven grading of brain gliomas: a multiparametric MR imaging study. Radiology 2014;272:494–503 doi:10.1148/radiol.14132040 pmid:24661247

   CrossRefPubMed
2. 2.↵
   2. Haegler K,
   3. Wiesmann M,
   4. Böhm C, et al

   . New similarity search based glioma grading. Neuroradiology 2012;54:829–37 doi:10.1007/s00234-011-0988-2 pmid:22160184

   CrossRefPubMed
3. 3.↵
   2. Hu LS,
   3. Eschbacher JM,
   4. Dueck AC, et al

   . Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma. AJNR Am J Neuroradiol 2012;33:69–76 doi:10.3174/ajnr.A2743 pmid:22095961

   Abstract/FREE Full Text
4. 4.↵
   2. Lemasson B,
   3. Valable S,
   4. Farion R, et al

   . In vivo imaging of vessel diameter, size, and density: a comparative study between MRI and histology. Magn Reson Med 2013;69:18–26 doi:10.1002/mrm.24218 pmid:22431289

   CrossRefPubMed
5. 5.↵
   2. Knopp EA,
   3. Cha S,
   4. Johnson G, et al

   . Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–98 doi:10.1148/radiology.211.3.r99jn46791 pmid:10352608

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Spampinato MV,
   3. Smith JK,
   4. Kwock L, et al

   . Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors. AJR Am J Roentgenol 2007;188:204–12 doi:10.2214/AJR.05.1177 pmid:17179366

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Law M,
   3. Yang S,
   4. Babb JS, et al

   . Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746–55 pmid:15140713

   Abstract/FREE Full Text
8. 8.↵
   2. Hilario A,
   3. Ramos A,
   4. Perez-Nuñez A, et al

   . The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas. AJNR Am J Neuroradiol 2012;33:701–07 doi:10.3174/ajnr.A2846 pmid:22207304

   Abstract/FREE Full Text
9. 9.↵
   2. Hakyemez B,
   3. Erdogan C,
   4. Ercan I, et al

   . High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Clin Radiol 2005;60:493–502 doi:10.1016/j.crad.2004.09.009 pmid:15767107

   CrossRefPubMed
10. 10.↵
    2. Khalid L,
    3. Carone M,
    4. Dumrongpisutikul N, et al

    . Imaging characteristics of oligodendrogliomas that predict grade. AJNR Am J Neuroradiol 2012;33:852–57 doi:10.3174/ajnr.A2895 pmid:22268087

    Abstract/FREE Full Text
11. 11.↵
    2. Bian W,
    3. Khayal IS,
    4. Lupo JM, et al

    . Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging. Transl Oncol 2009;2:271–80 doi:10.1593/tlo.09178 pmid:19956389

    CrossRefPubMed
12. 12.↵
    2. Guillevin R,
    3. Menuel C,
    4. Abud L, et al

    . Proton MR spectroscopy in predicting the increase of perfusion MR imaging for WHO grade II gliomas. J Magn Reson Imaging 2012;35:543–50 doi:10.1002/jmri.22862 pmid:22045581

    CrossRefPubMed
13. 13.↵
    2. Lin Y,
    3. Dawant BM

    . Automatic detection of the anterior and posterior commissures on MRI scans using regression forests. Conf Proc IEEE Eng Med Biol Soc 2014;2014:1505–08 doi:10.1109/EMBC.2014.6943887 pmid:25570255

    CrossRefPubMed
14. 14.↵
    2. Roy B,
    3. Gupta RK,
    4. Maudsley AA, et al

    . Utility of multiparametric 3-T MRI for glioma characterization. Neuroradiology 2013;55:603–13 doi:10.1007/s00234-013-1145-x pmid:23377234

    CrossRefPubMed
15. 15.↵
    2. Boxerman JL,
    3. Hamberg LM,
    4. Rosen BR, et al

    . MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995;34:555–66 doi:10.1002/(ISSN)1522-2594 pmid:8524024

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Emblem KE,
    3. Mouridsen K,
    4. Bjornerud A, et al

    . Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy. Nat Med 2013;19:1178–83 doi:10.1038/nm.3289 pmid:23955713

    CrossRefPubMed
17. 17.↵
    2. Troprès I,
    3. Lamalle L,
    4. Péoc'h M, et al

    . In vivo assessment of tumoral angiogenesis. Magn Reson Med 2004;51:533–41 doi:10.1002/(ISSN)1522-2594 pmid:15004795

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Kiselev VG,
    3. Strecker R,
    4. Ziyeh S, et al

    . Vessel size imaging in humans. Magn Reson Med 2005;53:553–63 doi:10.1002/(ISSN)1522-2594 pmid:15723391

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Hsu YY,
    3. Yang WS,
    4. Lim KE, et al

    . Vessel size imaging using dual contrast agent injections. J Magn Reson Imaging 2009;30:1078–84 doi:10.1002/jmri.21960 pmid:19856441

    CrossRefPubMed
20. 20.↵
    2. Choi SH,
    3. Chi JG,
    4. Kim YB, et al

    . Anterior commissure–posterior commissure revisited. Korean J Radiol 2013;14:653–61 doi:10.3348/kjr.2013.14.4.653 pmid:23901324

    CrossRefPubMed
21. 21.↵
    2. Jerome NP,
    3. Hekmatyar SK,
    4. Kauppinen RA

    . Blood oxygenation level dependent, blood volume, and blood flow responses to carbogen and hypoxic hypoxia in 9L rat gliomas as measured by MRI. J Magn Reson Imaging 2014;39:110–19 doi:10.1002/jmri.24097 pmid:23553891

    CrossRefPubMed
22. 22.↵
    2. Hu LS,
    3. Baxter LC,
    4. Pinnaduwage DS, et al

    . Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas. AJNR Am J Neuroradiol 2010;31:40–48 doi:10.3174/ajnr.A1787 pmid:19749223

    Abstract/FREE Full Text
23. 23.↵
    2. Paulson ES,
    3. Schmainda KM

    . Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 2008;249:601–13 doi:10.1148/radiol.2492071659 pmid:18780827

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Emblem KE,
    3. Nedregaard B,
    4. Nome T, et al

    . Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 2008;247:808–17 doi:10.1148/radiol.2473070571 pmid:18487536

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Deb P,
    3. Boruah D,
    4. Dutta V

    . Morphometric study of microvessels in primary CNS tumors and its correlation with tumor types and grade. Microvasc Res 2012;84:34–43 doi:10.1016/j.mvr.2012.03.004 pmid:22465694

    CrossRefPubMed
26. 26.↵
    2. Korkolopoulou P,
    3. Patsouris E,
    4. Konstantinidou AE, et al

    . Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas: associations with microvessel morphometry, proliferation and prognosis. Neuropathol Appl Neurobiol 2004;30:267–78 doi:10.1111/nan.2004.30.issue-3 pmid:15175080

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Sharma S,
    3. Sharma MC,
    4. Sarkar C

    . Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 2005;46:481–89 doi:10.1111/his.2005.46.issue-5 pmid:15842629

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Daumas-Duport C,
    3. Scheithauer B,
    4. O'Fallon J, et al

    . Grading of astrocytomas: a simple and reproducible method. Cancer 1988;62:2152–65 pmid:3179928

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Lemasson B,
    3. Chenevert TL,
    4. Lawrence TS, et al

    . Impact of perfusion map analysis on early survival prediction accuracy in glioma patients. Transl Oncol 2013;6:766–74 doi:10.1593/tlo.13670 pmid:24466380

    CrossRefPubMed
30. 30.↵
    2. Pannetier N,
    3. Lemasson B,
    4. Christen T, et al

    . Vessel size index measurements in a rat model of glioma: comparison of the dynamic (Gd) and steady-state (iron-oxide) susceptibility contrast MRI approaches. NMR Biomed 2012;25:218–26 doi:10.1002/nbm.v25.2 pmid:21751270

    CrossRefPubMed